Alzheimer's disease and the cell cycle

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• The reappearance of cell cycle markers is increasingly linked to early Alzheimer's disease (AD) pathogenesis.
• Neuronal vulnerability in early AD is associated with cell cycle reentry.
• Key AD pathologies, tau and amyloid, interact with cell cycle progression.

Purpose of the Study:

• To explore the mechanisms driving neuronal cell cycle reentry in early Alzheimer's disease.
• To identify novel molecular targets for pharmacological intervention in AD.
• To move beyond current cholinesterase inhibitor therapies by investigating proximal mechanisms.

Main Methods:

• Review and synthesis of current literature on cell cycle markers in Alzheimer's disease.
• Analysis of the interplay between amyloid, tau, and cell cycle progression.
• Identification of potential stimulatory and inhibitory signaling pathways involved in cell cycle reentry.

Main Results:

• Cell cycle reentry in neurons is a common early event in Alzheimer's disease.
• This reentry culminates in neuronal dysfunction, stasis, and eventual cell death (abortosis).
• Both tau and amyloid pathologies are implicated in or affected by cell cycle progression.

Conclusions:

• Understanding the precise mechanisms of cell cycle reentry in AD is crucial.
• Targeting these proximal mechanisms offers a promising avenue for developing new AD therapeutics.
• This approach could lead to interventions that alter the natural course of Alzheimer's disease.